• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirme

tetano

Editor, Senior Moderator
J Infect Dis. 2017 Aug 15;216(4):415-424. doi: 10.1093/infdis/jix268.
[h=1]Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.[/h] van Beek J[SUP]1[/SUP], Veenhoven RH[SUP]2[/SUP], Bruin JP[SUP]3[/SUP], van Boxtel RAJ[SUP]1[/SUP], de Lange MMA[SUP]1[/SUP], Meijer A[SUP]1[/SUP], Sanders EAM[SUP]1,[/SUP][SUP]4[/SUP], Rots NY[SUP]1[/SUP], Luytjes W[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Background:[/h] Data on the relative contribution of influenza virus and other respiratory pathogens to respiratory infections in community-dwelling older adults (≥60 years) are needed.
[h=4]Methods:[/h] A prospective observational cohort study was performed in the Netherlands during 2 winters. Nasopharyngeal and oropharyngeal swabs were collected during influenza-like illness (ILI) episodes and from controls. Viruses and bacteria were identified by multiplex ligation-dependent probe amplification assay and conventional bacterial culture.
[h=4]Results:[/h] The ILI incidence in the consecutive seasons was 7.2% and 11.6%, and influenza virus caused 18.9% and 34.2% of ILI episodes. Potential pathogen were detected in 80% of the ILI events with influenza virus, coronaviruses, rhinoviruses, human metapneumovirus, respiratory syncytial virus, parainfluenza viruses, and Haemophilus influenzae being the most common. Influenza vaccination reduced influenza virus infection by 73% (95% confidence interval [CI], 26%-90%) and 51% (95% CI, 7%-74%) in ILI patients. However, ILI incidence was similar between vaccinated (7.6% and 10.8%) and nonvaccinated (4.2% and 11.4%) participants in 2011-2012 and 2012-2013, respectively (P > .05).
[h=4]Conclusions:[/h] Influenza virus is a frequent pathogen in older adults with ILI. Vaccination reduces the number of influenza virus infections but not the overall number of ILI episodes: other pathogens fill the gap. We suggest the existence of a pool of individuals with high susceptibility to respiratory infections.
[h=4]Clinical Trials Registration:[/h] NTR3386.


[h=4]KEYWORDS:[/h] influenza virus; influenza virus infection; influenza-like illness; older adults; vaccination

PMID: 28931240 DOI: 10.1093/infdis/jix268
 
J Infect Dis. 2017 Aug 15;216(4):399-401. doi: 10.1093/infdis/jix269.
[h=1]Test-Negative Design: The Importance of Laboratory-Confirmed Illness in Estimating the Effectiveness of Influenza Vaccine in Older Adults.[/h] McElhaney JE[SUP]1[/SUP], McNeil SA[SUP]2[/SUP].
[h=3]Author information[/h]

[h=4]KEYWORDS:[/h] Influenza vaccine effectiveness; older adults; test negative design

PMID: 28931239 DOI: 10.1093/infdis/jix269
 
Back
Top Bottom